Medical Patent Law – The Challenges of Medical Treatment

Medical Patent Law – The Challenges of Medical Treatment

Eddy D. Ventose

This book provides a detailed and comparative examination of medical patent law and the issues at the heart of the medical treatment exclusion for therapeutic treatments, surgical treatments and diagnostic methods.

Chapter 7: Second and Further Medical Uses

Eddy D. Ventose

Subjects: law - academic, biotechnology and pharmaceutical law, health law, intellectual property law

Extract

A INTRODUCTION The drafters of the European Patents Convention (EPC) appreciated the importance of research and development to the pharmaceutical industry. However, for policy reasons, methods of medical treatment were excluded from patent protection in Article 53(c) EPC. Seemingly by way of compensation, the second sentence of Article 53(c) EPC provides that the methods of medical treatment exclusion shall not apply to products, in particular, substances or compositions, for use in any of these methods. In other words, substances used in treating patients remained patentable notwithstanding the medical treatment exclusion. A further and more important provision directly impacting the pharmaceutical industry was provided for in Article 54(5) EPC 19731 for medical uses of known substances and compositions. The inventive and innovative function of the patent system clearly is very pronounced in this field.2 Research into further medicinal uses of current drugs and known substances will be enhanced, and any refusal to recognise second-use patents would deprive inventors of their just reward. When a product is newly discovered, it can be claimed as a product and for that particular use. When a product is old, the exclusion of methods of medical treatment assumes particular significance because the claim would be for the product for use in a particular therapeutic method, that is a claim 1 This is now found in Article 54(4) EPC 2000 (see also Article 54(5) EPC 2000). The ideas in this chapter have been derived, in part, from the following: E. Ventose,...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information